Foghorn Therapeutics (FHTX) Tax Rate (2023)
Foghorn Therapeutics' quarterly Tax Rate came in at 8.98% in Q4 2023, down 65.54% quarter-over-quarter from 5.42% in Q3 2023.
Foghorn Therapeutics has reported Tax Rate for 1 years, with the latest figure at 8.98% in Q4 2023.
- For the quarter ending Q4 2023, Tax Rate changed N/A year-over-year to 8.98%; the trailing twelve-month figure through Sep 2024 stood at 2.23% (down 1.0% YoY), and the FY2023 full-year result was 4.49%, changed N/A from the prior year.
- Tax Rate for Q4 2023 stood at 8.98%, down from 5.42% in the prior quarter.
- The five-year high for Tax Rate was 1.87% in Q1 2023, with the low at 8.98% in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 57.14 |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 5.61 |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 17.68 |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | -6.79 |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 12.51 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 7.07 |
| 10 | Foghorn Therapeutics | 297.63 Mn | 208.72 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -8.98 |
| Dec 31, 2023 | -8.98 |
| Sep 30, 2023 | -5.42 |
| Sep 30, 2023 | -5.42 |
| Jun 30, 2023 | -3.30 |
| Jun 30, 2023 | -3.30 |
| Mar 31, 2023 | -1.87 |
| Mar 31, 2023 | -1.87 |